Scribe Therapeutics
Autoosa Salari is a Sr. Scientist at Scribe Therapeutics, with previous experience at CODA Biotherapeutics. Prior to that, Autoosa was a Scientist III at University of California, Berkeley, focusing on vision restoration methods for retinal degenerative disease. Autoosa holds a Ph.D. in Neuroscience from University of Missouri-Columbia and a B.A. in Molecular & Cell Biology from University of California, Berkeley.
Scribe Therapeutics
1 followers
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.